Annual Operating Margin
-26.54%
-23.88%-897.74%
December 31, 2023
Summary
- As of February 7, 2025, BGLC annual operating profit margin is -26.54%, with the most recent change of -23.88% (-897.74%) on December 31, 2023.
- During the last 3 years, BGLC annual operating margin has fallen by -37.72% (-337.39%).
- BGLC annual operating margin is now -194.08% below its all-time high of 28.21%, reached on December 1, 2018.
Performance
BGLC Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Margin
-50.85%
-63.98%-487.28%
September 30, 2024
Summary
- As of February 7, 2025, BGLC quarterly operating profit margin is -50.85%, with the most recent change of -63.98% (-487.28%) on September 30, 2024.
- Over the past year, BGLC quarterly operating margin has dropped by -63.98% (-487.28%).
- BGLC quarterly operating margin is now -245.41% below its all-time high of 34.97%, reached on March 1, 2020.
Performance
BGLC Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Margin Formula
Operating Profit Margin = Operating Profit
Revenue ✕ 100%
Revenue ✕ 100%
BGLC Operating Margin Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -897.7% | -487.3% |
3 y3 years | -337.4% | -2287.3% |
5 y5 years | -194.1% | -2287.3% |
BGLC Operating Margin Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -435.9% | at low | -487.3% | +48.6% |
5 y | 5-year | -337.4% | +87.8% | -245.4% | +64.7% |
alltime | all time | -194.1% | +87.8% | -245.4% | +84.1% |
BioNexus Gene Lab Operating Margin History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -50.85%(-487.3%) |
Jun 2024 | - | 13.13%(-495.5%) |
Mar 2024 | - | -3.32%(-129.3%) |
Dec 2023 | -26.54%(+897.7%) | 11.34%(-111.5%) |
Sep 2023 | - | -99.01%(+834.1%) |
Jun 2023 | - | -10.60%(+397.7%) |
Mar 2023 | - | -2.13%(-50.7%) |
Dec 2022 | -2.66%(-133.7%) | -4.32%(+70.8%) |
Sep 2022 | - | -2.53%(-54.4%) |
Jun 2022 | - | -5.55%(-582.6%) |
Mar 2022 | - | 1.15%(-81.5%) |
Dec 2021 | 7.90% | - |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | - | 6.20%(-40.5%) |
Sep 2021 | - | 10.42%(+130.0%) |
Jun 2021 | - | 4.53%(-54.3%) |
Mar 2021 | - | 9.92%(<-9900.0%) |
Dec 2020 | 11.18%(-105.1%) | -0.07%(-100.9%) |
Sep 2020 | - | 7.68%(-349.4%) |
Jun 2020 | - | -3.08%(-108.8%) |
Mar 2020 | - | 34.97%(-124.3%) |
Dec 2019 | -217.17%(-869.8%) | -144.13%(-37.1%) |
Sep 2019 | - | -229.28%(-28.3%) |
Jun 2019 | - | -319.79%(+49.2%) |
Mar 2019 | - | -214.34% |
Dec 2018 | 28.21% | - |
FAQ
- What is BioNexus Gene Lab annual operating profit margin?
- What is the all time high annual operating margin for BioNexus Gene Lab?
- What is BioNexus Gene Lab annual operating margin year-on-year change?
- What is BioNexus Gene Lab quarterly operating profit margin?
- What is the all time high quarterly operating margin for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly operating margin year-on-year change?
What is BioNexus Gene Lab annual operating profit margin?
The current annual operating margin of BGLC is -26.54%
What is the all time high annual operating margin for BioNexus Gene Lab?
BioNexus Gene Lab all-time high annual operating profit margin is 28.21%
What is BioNexus Gene Lab annual operating margin year-on-year change?
Over the past year, BGLC annual operating profit margin has changed by -23.88% (-897.74%)
What is BioNexus Gene Lab quarterly operating profit margin?
The current quarterly operating margin of BGLC is -50.85%
What is the all time high quarterly operating margin for BioNexus Gene Lab?
BioNexus Gene Lab all-time high quarterly operating profit margin is 34.97%
What is BioNexus Gene Lab quarterly operating margin year-on-year change?
Over the past year, BGLC quarterly operating profit margin has changed by -63.98% (-487.28%)